Copyright
©The Author(s) 2025.
World J Hepatol. Jan 27, 2025; 17(1): 101212
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.101212
Published online Jan 27, 2025. doi: 10.4254/wjh.v17.i1.101212
Table 1 Child-Pugh score
Variable | 1 point | 2 points | 3 points | Interpretation |
Serum albumin (mg/dL) | > 3.5 | 2.8–3.5 | < 2.8 | Sum of points: 5–6 = A; 7–9 = B; > 9 = C |
Serum bilirubin (mg/dL) | < 2 | 2–3 | > 3 | |
International normalized ratio | < 1.7 | 1.7–2.3 | > 2.3 | |
Ascites | None | Mild | Marked | |
Encephalopathy | None | Grade 1 and 2 | Grade 3 and 4 |
Table 2 Interpretation of model of end-stage liver disease score
Model of end-stage liver disease score | 3 months mortality (percentage) |
9 or less | 1.9 |
10–19 | 6 |
20–29 | 19.6 |
30–39 | 52.6 |
40 or above | 71.3 |
Table 3 Demographic and clinical characteristics of study population
Variable | Number | Mean (SD) | Percentage | Minimum | Maximum |
Age | - | 58.8 (17.4) | - | 15 | 90 |
Gender | Male = 405, female = 247 | - | 62.1, 37.9 | - | - |
Serum sodium (mEq/L) | - | 128.8 (6.2) | - | 120 | 149 |
Serum bilirubin (mg/dL) | - | 5.6 (5.0) | - | 0.8 | 25.3 |
Serum albumin (mg/dL) | - | 3.0 (0.9) | - | 1.2 | 4.9 |
Serum creatinine (mg/dL) | - | 2.1 (1.1) | - | 0.6 | 5.0 |
International normalized ratio | - | 1.9 (0.7) | - | 1.1 | 6.4 |
Hemoglobin (g/dL) | - | 11.1 (2.1) | - | 5.3 | 17.2 |
Child-Pugh score | - | 10.5 (2.6) | - | 6 | 15 |
MELD score | - | 23 (9) | - | 5 | 48 |
MELD-Na score | - | 27 (9) | - | 1 | 49 |
Table 4 Comparison of hemoglobin levels across Child-Pugh classes
Child-Pugh class | Number of patients | Mean hemoglobin (g/dL) | SD (g/dL) | Analysis of variance (F value) | P value |
A | 41 | 11.8 | 2.1 | 20.011 | 0.001 |
B | 211 | 11.7 | 1.9 | ||
C | 400 | 10.6 | 2.1 | ||
Total | 652 | 11.1 | 2.1 |
Table 5 Comparison of hemoglobin levels across model of end-stage liver disease score group
Group | Model of end-stage liver disease score range | Number of patients | Mean hemoglobin level (g/dL) | SD (g/dL) | Analysis of variance (F value) | P value |
1 | < 10 | 33 | 12.6 | 1.8 | 13.042 | 0.001 |
2 | 10–19 | 236 | 11.5 | 2.0 | ||
3 | 20–29 | 165 | 10.7 | 2.0 | ||
4 | 30–39 | 181 | 10.7 | 1.9 | ||
5 | > 39 | 37 | 9.8 | 1.9 | ||
Total | 652 | 11.1 | 2.0 |
Table 6 Comparison of hemoglobin levels across model of end-stage liver disease-Na score groups
Group | Model of end-stage liver disease-Na score range | Number of patients | Mean hemoglobin level (g/dL) | SD (g/dL) | Analysis of variance (F value) | P value |
1 | < 10 | 22 | 12.0 | 2.1 | 9.6 | .001 |
2 | 10-19 | 119 | 11.5 | 2.0 | ||
3 | 20-29 | 192 | 11.4 | 2.1 | ||
4 | 30–39 | 274 | 10.7 | 1.9 | ||
5 | > 39 | 45 | 10.1 | 1.9 | ||
Total | 652 | 11.1 | 2.0 |
Table 7 Correlation of hemoglobin levels with clinical severity scores (Child-Pugh, model of end-stage liver disease, and model of end-stage liver disease-Na)
Correlation (Pearson) | R value | P value |
Hemoglobin vs Child-Pugh | -0.21 | < 0.01 |
Hemoglobin vs MELD | -0.26 | < 0.01 |
Hemoglobin vs MELD-Na | -0.25 | < 0.01 |
- Citation: Ullah H, Huma S, Yasin G, Ashraf M, Tahir N, Tahir Uddin Q, Shabana H, A R Hussein M, Shalaby A, Mossaad Alsayyad M, Said A, Farahat A, Hamed HI, Ayoub HSA, Imam MS, Elmahdi E. Comparison of different severity scores in correlating hemoglobin levels with the severity of hepatic decompensation: An observational study. World J Hepatol 2025; 17(1): 101212
- URL: https://www.wjgnet.com/1948-5182/full/v17/i1/101212.htm
- DOI: https://dx.doi.org/10.4254/wjh.v17.i1.101212